Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor
- PMID: 1915705
Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor
Abstract
Mice that are mutant at the op locus have a severe deficiency of mononuclear phagocytes due to an inactivating mutation in the CSF-1 (macrophage colony-stimulating factor, M-CSF) gene. op/op mice are toothless, possessing skeletal abnormalities, a low body weight, and compromised fertility; they are osteopetrotic due to a deficiency of osteoclasts. The congenital osteopetrosis, toothless phenotype, osteoclast deficit, and the defects in splenic and femoral macrophages were corrected by routes of administration of human recombinant CSF-1 that maintained normal circulating CSF-1 concentrations. Early restoration of circulating CSF-1 was required for rescue of the toothless phenotype, but only partially restored body weight. In contrast, the deficiencies of pleural and peritoneal cavity macrophages and the reduced female fertility were not corrected by restoration of circulating CSF-1. These results suggest that although circulating CSF-1 is required for osteoclast and macrophage production, local synthesis and action of the growth factor are important for certain target cell populations.
Similar articles
-
Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1.Mol Reprod Dev. 1997 Jan;46(1):85-91. doi: 10.1002/(SICI)1098-2795(199701)46:1<85::AID-MRD13>3.0.CO;2-2. Mol Reprod Dev. 1997. PMID: 8981368 Review.
-
Neonatal changes of osteoclasts in osteopetrosis (op/op) mice defective in production of functional macrophage colony-stimulating factor (M-CSF) protein and effects of M-CSF on osteoclast development and differentiation.J Submicrosc Cytol Pathol. 1996 Jan;28(1):13-26. J Submicrosc Cytol Pathol. 1996. PMID: 8929623
-
Role of CSF-1 in bone and bone marrow development.Mol Reprod Dev. 1997 Jan;46(1):75-83; discussion 83-4. doi: 10.1002/(SICI)1098-2795(199701)46:1<75::AID-MRD12>3.0.CO;2-2. Mol Reprod Dev. 1997. PMID: 8981367 Review.
-
Bone remodeling and macrophage differentiation in osteopetrosis (op) mutant mice defective in the production of macrophage colony-stimulating factor.J Submicrosc Cytol Pathol. 1998 Apr;30(2):239-47. J Submicrosc Cytol Pathol. 1998. PMID: 9648288
-
Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice.Bone. 1995 Jan;16(1):39. Bone. 1995. PMID: 7742081
Cited by
-
Cellular Organization of Neuroimmune Interactions in the Gastrointestinal Tract.Trends Immunol. 2016 Jul;37(7):487-501. doi: 10.1016/j.it.2016.05.003. Epub 2016 Jun 9. Trends Immunol. 2016. PMID: 27289177 Free PMC article. Review.
-
Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.J Exp Med. 1999 Jul 19;190(2):293-8. doi: 10.1084/jem.190.2.293. J Exp Med. 1999. PMID: 10432291 Free PMC article.
-
The influence of M-CSF on fracture healing in a mouse model.Sci Rep. 2021 Nov 16;11(1):22326. doi: 10.1038/s41598-021-01673-w. Sci Rep. 2021. PMID: 34785696 Free PMC article.
-
Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth.J Clin Invest. 1998 Apr 15;101(8):1557-64. doi: 10.1172/JCI2293. J Clin Invest. 1998. PMID: 9541484 Free PMC article.
-
Delayed hematopoietic development in osteopetrotic (op/op) mice.J Exp Med. 1993 Jan 1;177(1):237-42. doi: 10.1084/jem.177.1.237. J Exp Med. 1993. PMID: 8418205 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous